semaglutide discontinuation Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting | Diabetes Therapy Weight loss maintenance after discontinuing

In the SUSTAIN 7 trial, gastrointestinal adverse events occurred in 43-44% of semaglutide-treated patients and 33-48% of dulaglutide-treated patients (depending on dose)

Candoxatril (a selective NEP 24.11 inhibitor [24, 25]

Required Actions: Novo Nordisk must take immediate action to address the violations, including ceasing and desisting misleading promotional communications

Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al

What exactly are GLP-1 medications like Semaglutide and Tirzepatide

A 2026 scoping review found some fibers (like dextrins) showed the most consistent effect, but the studies were small and short, so the picture is still limited